Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
Total Valuation
Clinigence Holdings has a market cap or net worth of $632.67M. The enterprise value is $12.28B.
Market Cap$632.67M
Enterprise Value$12.28B
Share Statistics
Clinigence Holdings has 5,555,116 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,555,116
Owned by Insiders35.43%
Owned by Institutions5.67%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is 0.36 and return on invested capital (ROIC) is 20.91%.
Return on Equity (ROE)0.36
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)20.91%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee599.94K
Profits Per Employee65.22K
Employee Count800
Asset Turnover0.73
Inventory Turnover99.55
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 3.10. Clinigence Holdings’s PEG ratio is 0.07.
PE Ratio3.10
PS Ratio0.00
PB Ratio125.66
Price to Fair Value1.10
Price to FCF334.85
Price to Operating Cash Flow238.03
PEG Ratio0.07
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 479.95M and earned 52.18M in profits. Earnings per share was 10.23.
Revenue479.95M
Gross Profit196.26M
Operating Income130.62M
Pretax Income109.75M
Net Income52.18M
EBITDA148.65M
Earnings Per Share (EPS)10.23
Cash Flow
In the last 12 months, operating cash flow was 71.07M and capital expenditures -1.57M, giving a free cash flow of 69.50M billion.
Operating Cash Flow71.07M
Free Cash Flow69.50M
Free Cash Flow per Share12.51
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.27
52-Week Price Change1957.22%
50-Day Moving Average137.07
200-Day Moving Average62.92
Relative Strength Index (RSI)41.29
Average Volume (3m)155.00K
Important Dates
Clinigence Holdings upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Clinigence Holdings as a current ratio of 2.08, with Debt / Equity ratio of 278.73%
Current Ratio2.08
Quick Ratio2.06
Debt to Market Cap0.25
Net Debt to EBITDA2.00
Interest Coverage Ratio6.55
Taxes
In the past 12 months, Clinigence Holdings has paid 14.48M in taxes.
Income Tax14.48M
Effective Tax Rate0.13
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 3.08, with an EV/FCF ratio of 21.98.
EV to Sales0.95
EV to EBITDA3.08
EV to Free Cash Flow21.98
EV to Operating Cash Flow19.80
Balance Sheet
Clinigence Holdings has $87.67M in cash and marketable securities with $312.50M in debt, giving a net cash position of $224.83M billion.
Cash & Marketable Securities$87.67M
Total Debt$312.50M
Net Cash$224.83M
Net Cash Per Share$40.47
Tangible Book Value Per Share$33.81
Margins
Gross margin is 6.13%, with operating margin of 27.22%, and net profit margin of 10.87%.
Gross Margin6.13%
Operating Margin27.22%
Pretax Margin22.87%
Net Profit Margin10.87%
EBITDA Margin30.97%
EBIT Margin27.02%
Analyst Forecast
The average price target for Clinigence Holdings is $262.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$262.50
Price Target Upside124.65% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast141.25%
EPS Growth Forecast―